Rights and permissions
About this article
Cite this article
Intensive insulin therapy “highly cost-effective” in critical illness. Pharmacoecon. Outcomes News 483, 11 (2005). https://doi.org/10.2165/00151234-200504830-00029
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504830-00029